SIREN : 428955520
COLLIN is a French company founded 26 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in BAGNEUX (92220), this company of category PME shows in 2024 a revenue of 10.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10 704 890 € | 11 104 191 € | 10 706 717 € | 12 194 131 € | 9 958 201 € | 10 000 581 € | 11 199 448 € | 10 511 131 € | 9 646 918 € |
| Net income | -1 209 354 € | -1 202 919 € | -1 740 005 € | -470 665 € | -289 144 € | -424 973 € | 475 526 € | 251 446 € | 63 078 € |
| EBITDA | -772 821 € | -715 868 € | -1 371 508 € | -355 635 € | -145 553 € | -405 319 € | 744 469 € | 392 151 € | 141 552 € |
| Net margin | -11.3% | -10.8% | -16.3% | -3.9% | -2.9% | -4.2% | 4.2% | 2.4% | 0.7% |
In 2024, COLLIN achieves revenue of 10.7 M€. Revenue is growing positively over 9 years (CAGR: +1.3%). Slight decline of -4% vs 2023. After deducting consumption (5.3 M€), gross margin stands at 5.4 M€, i.e. a rate of 50%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -773 k€, representing -7.2% of revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -1.2 M€ (-11.3% of revenue), which will impact equity.
10 704 890 €
5 401 158 €
-772 821 €
-956 313 €
-1 209 354 €
-7.2%
The debt ratio (= Financial debt / Equity x 100) stands at 226%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 18%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
225.867%
17.572%
-9.589%
-4.434
10.3%
In 2024, the debt ratio of COLLIN (225.87) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
In 2024, the financial autonomy of COLLIN (17.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of COLLIN (-4.43) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 197.02. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
197.018
-30.632
In 2024, the liquidity ratio of COLLIN (197.02) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of COLLIN (-30.6x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 106 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 146 days. Excellent situation: suppliers finance 40 days of the operating cycle (retail model). Inventory turnover is 150 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 273 days of revenue, i.e. 8.1 M€ to permanently finance. Over 2016-2024, WCR increased by +146%, requiring additional financing.
8 129 079 €
106 j
146 j
150 j
273 j
Based on 124 transactions of similar company sales (all years), the value of COLLIN is estimated at 2 279 867 € (range 1 236 318€ - 6 905 756€). The price/revenue ratio is 0.21x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare COLLIN with other companies in the same sector:
The revenue of COLLIN in 2024 is 10.7 M€.
COLLIN recorded a net loss in 2024.
The headquarters of COLLIN is located in BAGNEUX (92220), in the department Hauts-de-Seine.
The tax return of COLLIN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
COLLIN operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.